(Credit-Archiegoodburn/Instagram)
“It’s a moment I’ll never forget, when I sat down at the edge of the pool – the pool where I’ve trained my whole life – to find out there’s a brain tumor”
In 2024, Archie Goodburn, a- young and promising 23-year-old athlete (currently 24-year-old) who won a bronze medal at a major junior championship and swam for Scotland, shared difficult news of being diagnosed with a rare form of cancer. This Scottish swimmer who has a record in the 50 m breaststroke found himself in a position where he might have to put a stopper on his dreams of competing in the Paris Olympic. He was diagnosed with incurable brain tumors. This discovery came after he experienced numbness and seizures, especially around the time he was trying to qualify for the Olympics.
Also Read: World Drug Day 2025: Why Is It Important For Us To Observe This Day?
Tests after the Olympic trials showed Archie has three large brain tumors called oligodendrogliomas that can't be removed with surgery. These tumors are rare and usually grow slowly, forming from a type of brain cell. While they're more often found in adults, they can affect anyone. Archie will now be undergoing radiotherapy and chemotherapy to treat them.
Also Read: Hundreds Report Pancreatitis After Using Weight-Loss Drugs; UK Launches A Study To Investigate
The brain tumor is in a critical area and is the leading cancer killer for people under 40, according to Brain Tumour Research.
Taking to social media Archie explained that he started having strange episodes of dizziness and was feeling uncomfortable in late 2023 that messed up his training. At first, they thought these were severe migraines. They caused him to lose strength, feel numb on his left side, and experience fear, nausea, and strong déjà vu. He now knows these were actually seizures.
Also Read: Hundreds Report Pancreatitis After Using Weight-Loss Drugs; UK Launches A Study To Investigate
According to the US National Cancer Institute, Oligodendroglioma is a type of tumor that starts in the brain or spinal cord. To correctly diagnose it, doctors look for two specific changes in the tumor's genes: a specific gene change called an IDH mutation and a particular loss of parts of chromosomes 1 and 19.
Archie on his Instagram account said, “My tumors express a mutation of my IDH1 gene that is shared with some forms of leukaemia.” According to a 2012 study published in the Brain Pathology, IDH1 gene is a mutation that happens in the early stages of brain development and is a common step in the development of brain tumors. This type of gene mutation is common in glial tumors, which are a type of tumor that originated in the glial cells present in the brain and spinal cord.
To get a clear diagnosis, doctors usually need to take a small piece of the tumor during surgery, if possible. A neuropathologist then looks at this piece of the tumor.
The National Cancer Institute explains that the causes of this brain tumor are still unknown. However, being exposed to radiation and having certain gene changes passed down in families might increase the chance of getting them.
Prognosis is about the likely outcome of the disease or the chance of recovery. It depends on several things: Type, grade, location, spread and severity of the type of tumor, specific gene changes, the patient's age, and how much of the tumor is left after surgery (if surgery was possible). Archie said, “IDH inhibiting medications, a new class of drug, have seen phenomenal developments in the last few years with some pretty amazing results. Continued progress in this field will aid my prognosis massively.”
About 79.5% of people with oligodendroglioma are still alive five years after diagnosis. However, one must remember that there are many things that affect this number. These include the tumor's grade and genetic makeup, the person's age and health when diagnosed, and how well they respond to treatment. If you want to understand your own outlook, it's best to talk to your doctor.
Despite the tough news, Archie is staying incredibly positive. He mentioned a "silver lining": these types of tumors often respond better to radiotherapy and chemotherapy than some other serious brain tumors. He also noted they usually grow slowly and might have been there for years.
Archie is determined to face this challenge head-on. He's drawing strength from being young and fit, and from the amazing support he gets from his friends, family, and girlfriend. He plans to "remain positive and to keep being Archie." Many people have applauded his strength and resilience to bring awareness about the disease “I'm lucky... I've got time to shout about this disease.”
Due to the massive popularity of magnesium and its potential health benefits, many parents had incorporated it into their kid’s consumption as well. However, the UK government has asked for parents and caregivers to immediately stop giving Nutrition Ignition Kids Magnesium Glycinate Gummies to children.
The Medicines and Healthcare products Regulatory Agency (MHRA) found an unlisted medicine, melatonin, in the product. It's important to safely throw away any gummies you have left and to talk to a doctor if you're worried about your child's health.
The MHRA discovered that the gummies, sold online as a food supplement, contain melatonin, even though it is not on the label. Each gummy has 1.5 to 1.7 milligrams of melatonin. This is a lot, especially since the recommended starting dose for children who need melatonin is only 1 milligram. The gummies were marketed for "calm, focus, and digestion" for kids ages four and older, but they contain a powerful, unlisted drug.
Taking too much melatonin can cause side effects like drowsiness, headaches, dizziness, and nausea. While these issues are not expected to cause lasting harm and the body typically clears the drug within 12 hours, the MHRA has already removed the product from online stores. Dr. Alison Cave, the MHRA's Chief Safety Officer, also pointed out that other possible side effects from melatonin in children can be hyperactivity and stomach pain.
It is very important that you do not throw these gummies in the regular trash. Instead, you should store them securely in a container that children cannot open and keep them out of their reach. When you can, take the gummies to any local pharmacy for safe disposal. If you think your child had a bad reaction to the product, stop giving it to them right away and talk to a doctor. You can also report the side effect to the MHRA's Yellow Card scheme.
Credits: Canva
Nepal has officially been verified for rubella elimination. This makes it a milestone in global public health and putting the country among six in the World Health Organization’s (WHO) South-East Asia Region to achieve this feat.
The announcement was made at the 10th meeting of the Regional Verification Commission for Measles & Rubella Elimination, held from July 22 to 24, 2025, where progress across all 10 member states was reviewed.
The WHO has set 2026 as the target year to eliminate both measles and rubella from the region, a goal it described as ambitious but attainable if countries sustain momentum and strengthen cooperation.
Nepal’s achievement was the result of decades of determined efforts, robust immunization campaigns, and innovative community-level outreach.
The country introduced the rubella-containing vaccine in 2012 through a nationwide campaign that reached children between nine months and 15 years of age.
In 2016, a second dose was added to the routine immunization schedule, further boosting protection.
Regular follow-up campaigns, conducted every four years in 2012, 2016, 2020, and 2024, helped plug immunization gaps, even during times of crisis.
For instance, vaccination drives continued during the devastating earthquakes of 2015 and 2023, ensuring that immunization momentum was not lost.
By 2024, Nepal had achieved more than 95% coverage with at least one dose of the rubella vaccine, creating herd immunity levels strong enough to halt the spread of the virus.
The country also introduced innovative strategies, such as an annual “Immunization Month,” mobile outreach programs to reach missed children, and the declaration of “fully immunized districts” to hold local leaders accountable.
On the surveillance front, Nepal has been equally rigorous. Laboratory-supported rubella case surveillance began as early as 2004, while congenital rubella syndrome (CRS) surveillance started in 2014.
These systems consistently exceeded elimination targets. Most recently, Nepal introduced a robust laboratory testing algorithm, the first of its kind in the region—that allows more accurate detection of true rubella cases.
Rubella, often called “German measles,” is a viral infection that spreads through droplets from coughs and sneezes. While symptoms are usually mild in children and adults, fever, rash, and swollen lymph nodes, the disease can have devastating consequences during pregnancy. Infection in expectant mothers can cause miscarriage, stillbirth, or congenital rubella syndrome, a condition leading to lifelong disabilities including hearing and vision impairment, heart defects, and developmental delays.
According to WHO, before the widespread introduction of vaccines, rubella was a leading cause of preventable congenital disabilities worldwide. Elimination is defined as the absence of endemic transmission for at least 12 months, supported by a high-performing surveillance system.
The South-East Asia Region has made significant strides, but challenges remain. Six countries, including Nepal, have eliminated rubella, while four have eliminated measles. However, WHO cautioned that setbacks caused by global geopolitical crises, funding shortages, and disruptions during the COVID-19 pandemic have slowed progress.
At the regional commission meeting, experts urged governments and international partners to redouble efforts, ensure sustainable funding, and strengthen collaboration if the 2026 elimination target is to be met.
“The region has shown what is possible with political will and community participation,” the Commission said in a statement, commending Nepal for its achievement. “But urgent, accelerated actions are needed to protect these gains and prevent resurgence.”
(Credit - Canva)
Valley Fever California: As cases of Valley fever increase in California, California Department of Public Health (CDPH) have put out a warning to ensure people stay safe. With more than 5,500 cases of valley fever in the first six months, the current number of cases being 6,761, health officials have detailed things California residents or visitors should know.
The highest rates of Valley fever are in the southern San Joaquin Valley, but cases are increasing in other parts of the Central Valley and the Central Coast. According to CDPH Director Dr. Erica Pan, it's crucial for residents, visitors, and healthcare providers to be aware of the signs and symptoms for early detection.
According to the Centre of Disease Control And Prevention, Valley fever (coccidioidomycosis) is a lung infection caused by the fungus Coccidioides, which lives in the soil. This fungus is found primarily in the Pacific Northwest and southwestern United States, as well as parts of Mexico, Central America, and South America. People become infected by breathing in the fungal spores.
It's important to note that Valley fever is not contagious; it cannot be spread from person to person or from animals to people. While some people who are exposed to the spores never get sick, others develop symptoms of a typical lung infection, such as a cough and fever.
Also Read: First Rocky Mountain Spotted Fever Case Confirmed In Quebec
The disease can be challenging to diagnose because its symptoms are similar to those of other viral or bacterial pneumonias, leading to potential misdiagnosis, ineffective treatments, or delays in getting the proper care. Early treatment with antifungal medication can be lifesaving for those who need it.
The illness can cause symptoms that resemble the flu or COVID-19, and it can also lead to serious lung infections like pneumonia. The fungus is often stirred up in late summer and fall, and people typically get sick one to three weeks after breathing it in. The symptoms of Valley fever can vary greatly from person to person. While some individuals have no symptoms at all, others may experience:
In some cases, Valley fever can lead to more serious health issues. About 5 to 10% of people who contract the infection will develop long-term problems in their lungs.
In a very small percentage of cases (about 1%), the infection can spread from the lungs to other parts of the body. This is known as a disseminated infection and can affect the skin, bones, joints, or even the brain, leading to a condition called meningitis. Certain groups of people are at a higher risk for developing these more severe forms of the illness.
Many people who get Valley fever get better on their own without needing any special medicine. Their symptoms usually go away in a few weeks or months. However, some people need medical care to feel better or to keep the infection from getting worse.
For very bad infections or cases where the fungus has spread to other parts of the body, doctors must use antifungal medication. These people may also need to stay in the hospital.
Valley fever is not contagious, so you can't catch it from another person or pet. You and your pets can only get it by breathing in dust that contains the fungus. It can be hard to completely prevent Valley fever, but you can take steps to lower your risk:
© 2024 Bennett, Coleman & Company Limited